Physostigmine: Clinical Trials

9 trials of Physostigmine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 unknown. 5 Not applicable, 2 Phase 3, 1 Early Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable5Completed 3, Unknown 2
Phase 32Completed 1, Unknown 1
Early Phase 11Completed 1
Phase 41Completed 1

Follow Physostigmine: new trials by email Literature Review of Physostigmine trials Research Report on Physostigmine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Adolescent Antimuscarinic (Anticholinergic) Toxidrome
Physostigmine, Lorazepam - Anticholinergics Toxicity
Phase 4CompletedUniversity of Colorado, Denver192017-03-302021-08-23
Anticholium® Per Se
Physostigmine, Isotonic Saline - Shock, Septic, Sepsis
Not applicableCompletedUniversity Hospital Heidelberg202015-01-282018-01-29
Evaluation if Physostigmine Reduces Symptoms in Patients Who Has Developed a Delirium in Intensive Care After a Surgery
Physostigmine, Sodium Chloride solution - Suspected Delirium After Elective or Emergency Heart Surgery, CAM-ICU Diagnosed Delirium
Phase 3UnknownPD Dr. Bertram Scheller1202014-04-012017-03-10
Acetylcholine, Tobacco Smoking, Genes and Nicotinic Receptors
Physostigmine - Smoking, Schizophrenia
Not applicableCompletedYale University802013-09-012023-10-25
Pilot Study of Physostigmine-Enhanced Opioid Analgesia
Physostigmine, Placebo - Postoperative Pain
Phase 3CompletedMedical University of Graz202011-06-012012-02-22
The Effect of Physostigmine on Cognitive Functioning in the Immediate Period After Sedation for Colonoscopy
Physostigmine - Cognitive Dysfunction
Not applicableUnknownRabin Medical Center1602010-07-012010-05-12
Physostigmine After General Anesthesia
physostigmine, Isotonic sodium chloride solution - Postoperative Nausea and Vomiting, Anesthesia Recovery Period
Not applicableUnknownBispebjerg Hospital502009-12-012010-05-27
Phamacological Reversal of Airway Instability During Sedation
Physostigmine, Oxygen, Placebo - Upper Airway Obstruction
Not applicableCompletedUniversity of Rochester102009-08-012015-04-27
Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity
Atropine, Physostigmine, Placebo Sodium - Insulin Resistance
Early Phase 1CompletedAstraZeneca122007-05-012009-03-13

Conditions studied

Airway Obstruction (1)  ·  Cognitive Dysfunction (1)  ·  Delirium (1)  ·  Insulin Resistance (1)  ·  Pain, Postoperative (1)  ·  Postoperative Nausea and Vomiting (1)  ·  Respiratory Aspiration (1)  ·  Schizophrenia (1)  ·  Sepsis (1)  ·  Shock, Septic (1)  ·  Smoking (1)

Sponsors

AstraZeneca (1)  ·  Bispebjerg Hospital (1)  ·  Medical University of Graz (1)  ·  PD Dr. Bertram Scheller (1)  ·  Rabin Medical Center (1)  ·  University Hospital Heidelberg (1)  ·  University of Colorado, Denver (1)  ·  University of Rochester (1)  ·  Yale University (1)

Countries

United States (3)  ·  Germany (2)  ·  Austria (1)  ·  Denmark (1)  ·  Israel (1)  ·  Sweden (1)

Top investigators

Bertram Scheller, MD (1)  ·  Bezion Beilin, MD (1)  ·  Frank Pott, MD (1)  ·  George S Wang, MD (1)  ·  Gudrun Rumpold-Seitlinger, MD (1)  ·  Jan Eriksson, MSD (1)  ·  Johannes B Zimmermann, MD, MSc (1)  ·  Kelly Cosgrove, PhD (1)  ·  Per-Anders Jansson, prof (1)  ·  Suzanne B Karan, Medical (1)

Results publications

PMID 29126416, PMID 31035187, PMID 31398669

NIH funding

K23DA045957 (1), R01DA015577 (1), R01DA038832 (1)